# Artiva Biotherapeutics, Inc.: Form 8-K, filed Jun 25, 2025

- Company: [Artiva Biotherapeutics, Inc.](/companies/artv.md) (CIK 1817241)
- Form: 8-K
- Filed: 2025-06-25
- Accepted by EDGAR: Jun 25, 2025, 16:02 ET
- Period: 2025-06-24
- Accession: 0000950170-25-089942
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817241/000095017025089942/artv-20250624.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817241/000095017025089942/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817241/000095017025089942/artv-20250624.htm

Filed Jun 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-089942. Last ingested by Listed: Oct 27, 2026, 08:31 ET. No prices; not investment advice.